olaparib
astrazeneca,merck
['urothelial carcinoma', 'urothelial', 'gu ', 'olaparib', 'congrat', 'prostate']
congratulations to , our advanced gu oncology fellow at working with , for two poster presentations at asco 2023: dmmr and msi-h in urothelial carcinoma and trial in progress of olaparib in non-prostate gu tumors (nct03375307) #asco2023 
Highlighting clinical research in Medical Oncology at CCR/NCI. Official Twitter account of the NCI MOS. Privacy: https://t.co/gFvBNAjaVl